ramipril tad 1,25 mg tabletes
tad pharma gmbh, germany - ramiprils - tabletes - 1,25 mg
ramipril tad 5 mg tabletes
tad pharma gmbh, germany - ramiprils - tablete - 5 mg
ramipril tad 2,5 mg tabletes
tad pharma gmbh, germany - ramiprils - tablete - 2,5 mg
ramipril tad 10 mg tabletes
tad pharma gmbh, germany - ramiprils - tablete - 10 mg
ramipril actavis 5 mg tabletes
teva b.v., netherlands - ramiprils - tablete - 5 mg
ramipril actavis 10 mg tabletes
teva b.v., netherlands - ramiprils - tablete - 10 mg
ramlon 2,5 mg/2,5 mg cietās kapsulas
egis pharmaceuticals plc, hungary - ramiprilum, amlodipinum - kapsula, cietā - 2,5 mg/2,5 mg
maxitrol acu pilieni, suspensija
novartis baltics, sia, latvia - dexamethasonum, neomycini sulfas, polymyxini b sulfas - acu pilieni, suspensija - 1 mg/3500sv/6000 sv/ml
entresto
novartis europharm limited - sacubitril, valsartan - sirdskaite - angiotensīna ii antagonisti, citas kombinācijas, līdzekļi, kas iedarbojas uz renin-angiotensīna sistēmu - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
neparvis
novartis europharm limited - sacubitril, valsartan - sirdskaite - agents, kas iedarbojas uz renīna-angiotenzīna sistēmu - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.